<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03728946</url>
  </required_header>
  <id_info>
    <org_study_id>2018016</org_study_id>
    <nct_id>NCT03728946</nct_id>
  </id_info>
  <brief_title>Interscalene Block With and Without Liposomal Bupivacaine in Shoulder Surgery</brief_title>
  <official_title>Interscalene Block With and Without Liposomal Bupivacaine in Shoulder Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Orthopaedic &amp; Neurosurgery Specialists</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Orthopaedic &amp; Neurosurgery Specialists</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the difference in perioperative pain after shoulder
      surgery with a standard bupivacaine nerve block compared to liposomal bupivacaine enhanced
      nerve block alone in TSA and ARCR. Data will be compared using VAS scores and opiate
      consumption between the two groups. The hypothesis of this study is that an interscalene
      nerve block with liposomal bupivacaine will decrease both postoperative VAS pain scores and
      total narcotic consumption when compared to a standard bupivacaine interscalene nerve block
      alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Arthroscopic rotator cuff repair (ARCR) and shoulder arthroplasty (TSA) provide excellent
      clinical outcomes but are often associated with significant postoperative pain, frequently
      managed with oral opioid medication. Orthopedic surgeons prescribe approximately 32 unused
      pills per shoulder surgery and are the third largest prescribers of opiates in the USA. It is
      incumbent upon the orthopedic community to identify postoperative pain management methods
      which reduce the need for narcotic medication following shoulder procedures as a means to
      mitigate the impact of orthopedic procedures on this epidemic.

      The use of intraoperative local and regional anesthesia or field blocks, in conjunction with
      multimodal pharmacological strategies, is an accepted approach for managing surgical pain and
      reducing opiate use but requires peer reviewed protocols to gain wider acceptance.

      Interscalene nerve block with bupivacaine remains a gold standard for peri-operative
      analgesia, but is associated with significant rebound pain due to the short duration of the
      local anesthetics. Recent studies have demonstrated that the addition of a liposomal
      bupivacaine field block may lower pain and enhance patient satisfaction throughout the first
      postoperative week. Liposomal bupivacaine has recently received FDA approval for ISB, but the
      data regarding its efficacy in nerve blocks is sparse.

      The purpose of this pilot study is to determine if liposomal bupivacaine-enhanced
      interscalene nerve blocks can be used to improve peri-operative pain control methods, limit
      narcotic use, and provide appropriate postoperative analgesia compared to standard
      bupivacaine blocks. Primary and secondary outcome measures will be collected as number of
      opiates taken and self-reported VAS pain scores over a 14 day postoperative period,
      respectively.

      The hypothesis of this study is that an interscalene nerve block with liposomal bupivacaine
      will decrease both postoperative VAS pain scores and total narcotic consumption when compared
      to a standard bupivacaine interscalene nerve block alone.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 21, 2018</start_date>
  <completion_date type="Actual">March 1, 2020</completion_date>
  <primary_completion_date type="Actual">March 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opiate Consumption</measure>
    <time_frame>Post-operative days 1-14</time_frame>
    <description>Total amount of narcotics consumed during the postoperative period, measured in morphine equivalents (OME)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>VAS Pain Scores</measure>
    <time_frame>Post operative days 1-14</time_frame>
    <description>A standardized measure of subjective pain on a scale of 0 to 10, from zero pain to excruciating pain, respectively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Likert Pain Satisfaction Rating</measure>
    <time_frame>Post operative days 1-14</time_frame>
    <description>A standardized measure of patient satisfaction with pain management from 1 (very unsatisfied) to 5 (very satisfied)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Rotator Cuff Tear</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Liposomal Bupivacaine Interscalene Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Liposomal bupivacaine anesthetic will be administered as an interscalene block during rotator cuff repair surgery and total shoulder arthroplasty.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine Interscalene Block</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Bupivacaine anesthetic will be administered as an interscalene block during rotator cuff repair surgery and total shoulder arthroplasty.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Liposomal Bupivacaine</intervention_name>
    <description>Addition of 15mL of liposomal bupivacaine to 15mL of standard nerve block anesthetic solution containing 0.5% bupivacaine and 4mg of decadron</description>
    <arm_group_label>Liposomal Bupivacaine Interscalene Block</arm_group_label>
    <other_name>EXPAREL</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over 18 undergoing rotator cuff repair or total shoulder arthroplasty

        Exclusion Criteria:

          -  Pregnant

          -  Documented drug of alcohol abuse

          -  Active narcotic use prior to surgery

          -  Neurological deficit

          -  Allergy to amide anesthetics

          -  Not cleared by primary care physician

          -  Hydrocodone or oxycodone intolerance

          -  Enrollment in another clinical trial or past cognitive or mental health status that
             interferes with study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Greenwich Hospital</name>
      <address>
        <city>Greenwich</city>
        <state>Connecticut</state>
        <zip>06830</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopaedic &amp; Neurosurgery Specialists</name>
      <address>
        <city>Greenwich</city>
        <state>Connecticut</state>
        <zip>06831</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stamford Ambulatory Surgical Center</name>
      <address>
        <city>Stamford</city>
        <state>Connecticut</state>
        <zip>06902</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Atlantis Orthopaedics</name>
      <address>
        <city>Atlantis</city>
        <state>Florida</state>
        <zip>06831</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Atlantis Orthopaedics</name>
      <address>
        <city>Palm Beach Gardens</city>
        <state>Florida</state>
        <zip>33410</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern Oregon Orthopedics, Inc.</name>
      <address>
        <city>Medford</city>
        <state>Oregon</state>
        <zip>97504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kumar K, Gulotta LV, Dines JS, Allen AA, Cheng J, Fields KG, YaDeau JT, Wu CL. Unused Opioid Pills After Outpatient Shoulder Surgeries Given Current Perioperative Prescribing Habits. Am J Sports Med. 2017 Mar;45(3):636-641. doi: 10.1177/0363546517693665. Epub 2017 Feb 9.</citation>
    <PMID>28182507</PMID>
  </reference>
  <reference>
    <citation>Lee CY, Robinson DA, Johnson CA Jr, Zhang Y, Wong J, Joshi DJ, Wu TT, Knight PA. A Randomized Controlled Trial of Liposomal Bupivacaine Parasternal Intercostal Block for Sternotomy. Ann Thorac Surg. 2019 Jan;107(1):128-134. doi: 10.1016/j.athoracsur.2018.06.081. Epub 2018 Aug 28.</citation>
    <PMID>30170012</PMID>
  </reference>
  <reference>
    <citation>Pedoto A, Amar D. Liposomal Bupivacaine for Intercostal Nerve Block: Pricey or Priceless? Semin Thorac Cardiovasc Surg. 2017 Winter;29(4):538-539. doi: 10.1053/j.semtcvs.2017.08.016. Epub 2017 Aug 30.</citation>
    <PMID>28967536</PMID>
  </reference>
  <reference>
    <citation>Rice DC, Cata JP, Mena GE, Rodriguez-Restrepo A, Correa AM, Mehran RJ. Posterior Intercostal Nerve Block With Liposomal Bupivacaine: An Alternative to Thoracic Epidural Analgesia. Ann Thorac Surg. 2015 Jun;99(6):1953-60. doi: 10.1016/j.athoracsur.2015.02.074. Epub 2015 Apr 23.</citation>
    <PMID>25912739</PMID>
  </reference>
  <reference>
    <citation>Surdam JW, Licini DJ, Baynes NT, Arce BR. The use of exparel (liposomal bupivacaine) to manage postoperative pain in unilateral total knee arthroplasty patients. J Arthroplasty. 2015 Feb;30(2):325-9. doi: 10.1016/j.arth.2014.09.004. Epub 2014 Sep 16.</citation>
    <PMID>25282071</PMID>
  </reference>
  <reference>
    <citation>Vandepitte C, Kuroda M, Witvrouw R, Anne L, Bellemans J, Corten K, Vanelderen P, Mesotten D, Leunen I, Heylen M, Van Boxstael S, Golebiewski M, Van de Velde M, Knezevic NN, Hadzic A. Addition of Liposome Bupivacaine to Bupivacaine HCl Versus Bupivacaine HCl Alone for Interscalene Brachial Plexus Block in Patients Having Major Shoulder Surgery. Reg Anesth Pain Med. 2017 May/Jun;42(3):334-341. doi: 10.1097/AAP.0000000000000560.</citation>
    <PMID>28157791</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>October 31, 2018</study_first_submitted>
  <study_first_submitted_qc>October 31, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2018</study_first_posted>
  <last_update_submitted>March 22, 2020</last_update_submitted>
  <last_update_submitted_qc>March 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Orthopaedic &amp; Neurosurgery Specialists</investigator_affiliation>
    <investigator_full_name>Paul Sethi</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rotator Cuff Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

